Skip to main content
NCBI home page
Applied Microbiology logoLink to Applied Microbiology
. 1969 Sep;18(3):404–405. doi: 10.1128/am.18.3.404-405.1969

In Vitro Activity of Coumermycin A1 Against Mycobacterium tuberculosis var. hominis

Richard J Duma 1, John F Warner 1
PMCID: PMC377993  PMID: 4984765

Abstract

Coumermycin A1 exhibited in vitro activity against eight strains of Mycobacterium tuberculosis var. hominis. All eight strains were inhibited by levels of 2.5 μg/ml, and six of the eight strains were inhibited by levels of 0.3 μg/ml or less.

Full text

PDF
404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger J., Schocher A. J., Batcho A. D., Pecherer B., Keller O., Maricq J., Karr A. E., Vaterlaus B. P., Furlenmeier A., Speigelberg H. Production, isolation, and synthesis of the coumermycins (sugordomycins), a new streptomycete antibiotic complex. Antimicrob Agents Chemother (Bethesda) 1965;5:778–785. [PubMed] [Google Scholar]
  2. Grunberg E., Bennett M. Chemotherapeutic properties of coumermycin A1. Antimicrob Agents Chemother (Bethesda) 1965;5:786–788. [PubMed] [Google Scholar]
  3. KAWAGUCHI H., TSUKIURA H., OKANISHI M., MIYAKI T., OHMORI T., FUJISAWA K., KOSHIYAMA H. STUDIES ON COUMERMYCIN, A NEW ANTIBIOTIC. I. PRODUCTION, ISOLATION AND CHARACTERIZATION OF COUMERMYCIN A1. J Antibiot (Tokyo) 1965 Jan;18:1–10. [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES